Synthesis Pharmaceutical Private Limited
About Synthesis Pharmaceutical Private Limited
Data last updated:
Synthesis Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2011PTC027222. Its GSTIN is 23AARCS8508B1ZC (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka Kesharwani and Sanjay Kumar Kesharwani.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 Ishwar Apartment 80 Chandralok Colony Saket Nagar, Indore, Madhya Pradesh, India – 452018.
As per the financials filed for FY 2024, the company reported a revenue of ₹98.67 Lakh, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹3.26 Lakh (net margin 3.3%) and EBITDA of ₹4.84 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address201 Ishwar Apartment 80 Chandralok Colony Saket Nagar, Indore, Madhya Pradesh, India – 452018
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Synthesis Pharmaceutical Private Limited
The main business activity of Synthesis Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Synthesis Pharmaceutical Private Limited FY 2025 filings available
Synthesis Pharmaceutical Private Limited reported revenue of ₹98.67 Lakh (up 34% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Synthesis Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 34% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Synthesis Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.84 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.26 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Synthesis Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synthesis Pharmaceutical are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Synthesis Pharmaceutical Private Limited
Synthesis Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vincor Life Sciences Private Limited | ₹99.01 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Ceras Pharmaceuticals Private Limited | ₹98.98 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| N.E.W.S. Pharma Private Limited | ₹98.94 Lakh (FY 2022) | •••• | •••• | -9.0% | •••• | Panchkula, Haryana, India |
| Lifezest Medicare Private Limited | ₹98.89 Lakh (FY 2023) | •••• | •••• | 160.0% | •••• | Pune, Maharashtra, India |
| Medizin Labs Private Limited | ₹98.78 Lakh (FY 2019) | •••• | •••• | 7.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Synthesis Pharmaceutical Private Limited this company | ₹98.67 Lakh (FY 2024) | •••• | •••• | 34.0% | •••• | Indore, Madhya Pradesh, India |
| Medikon India Private Limited | ₹98.65 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Morgan Drugs Private Limited | ₹98.64 Lakh (FY 2019) | •••• | •••• | 6.0% | •••• | Lakhisarai, Bihar, India |
| Venus Holistic Services Private Limited | ₹98.57 Lakh (FY 2021) | •••• | •••• | -41.0% | •••• | Hyderabad, Telangana, India |
| Regalia Pharmaceutical (India) Private Limited | ₹98.56 Lakh (FY 2024) | •••• | •••• | -15.0% | •••• | Pune, Maharashtra, India |
| S.G.P.Exim Private Limited | ₹98.46 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Synthesis Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Synthesis Pharmaceutical Private Limited
Synthesis Pharmaceutical Private Limited is audited by S A M V A D & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S A M V A D & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Synthesis Pharmaceutical Private Limited
Synthesis Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Kesharwani | Director | 30 Nov 2011 | 14 Years 10 Months | Current |
| Sanjay Kumar Kesharwani | Director | 30 Nov 2011 | 14 Years 10 Months | Current |
Ownership and Shareholding of Synthesis Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Synthesis Pharmaceutical Private Limited
Synthesis Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Synthesis Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Synthesis Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Synthesis Pharmaceutical Private Limited
Synthesis Pharmaceutical Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Priyanka Kesharwani was appointed as Director on 30 Nov 2011.
Credit Ratings, Litigation & Regulatory Alerts for Synthesis Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Synthesis Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synthesis Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Synthesis Pharmaceutical Private Limited
Synthesis Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AARCS8508B1ZC | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synthesis Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synthesis Pharmaceutical Private Limited
Synthesis Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 November 2011 (15+ years old) and is registered under CIN U24232MP2011PTC027222.
Synthesis Pharmaceutical reported revenue of ₹98.67 Lakh for FY 2024 (up 34% YoY).
Synthesis Pharmaceutical has 2 current directors:
- Priyanka Kesharwani - Director
- Sanjay Kumar Kesharwani - Director
Synthesis Pharmaceutical reported a net profit of ₹3.26 Lakh (net margin 3.3%) and EBITDA of ₹4.84 Lakh (EBITDA margin 4.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Synthesis Pharmaceutical is 32% over three years and 8% over five years. In the latest year (FY 2024) revenue rose 34%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Synthesis Pharmaceutical is 23AARCS8508B1ZC, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Synthesis Pharmaceutical is U24232MP2011PTC027222. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synthesis Pharmaceutical was incorporated on 30 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Synthesis Pharmaceutical by revenue are Vincor Life Sciences Private Limited, Ceras Pharmaceuticals Private Limited, N.E.W.S. Pharma Private Limited, Lifezest Medicare Private Limited, Medizin Labs Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Priyanka Kesharwani was appointed as Director on 30 Nov 2011. Sanjay Kumar Kesharwani was appointed as Director on 30 Nov 2011.
The registered office of Synthesis Pharmaceutical is at 201 Ishwar Apartment 80 Chandralok Colony Saket Nagar, Indore, Madhya Pradesh, India – 452018.